Alphabet is no longer feeding X, the department for particularly daring ideas, as usual. Third parties are to step in.

AI drug design and development company Isomorphic Labs announced ... CEO Hassabis: “Funding will turbocharge AI drug design mission” In a statement Isomorphic Labs founder and CEO, Sir Demis ...

In this article, we are going to take a look at where Alphabet ... company, claiming that the transition will be a bad idea, which prioritizes commercial interests and compromises its mission ...